- Email: [email protected]
Scientific Exhibits
Scientific Exhibits November 8 - 12 Dallas Convention Center Exhibit Hall Level 2
Academy scientific exhibits will be displayed Sunday through Wednesday, from 8:00 am - 5:00 pm, and Thursday, from 8:00 am - 3:00 pm.
Exhibits will be staffed throughout the meeting.
157
SCIENTIFIC EXHIBITS Scientific Exhibit 1
*
Developing Interactive Multimedia Instruction for Ophthalmology
Robert Folberg, MD; Laura K Dickinson; Laurie A Smith, Iowa City, lA The Educational Resources Group is a division of the Department of Ophthalmology at the University of Iowa. This group has successfully designed and produced interactive multimedia medical programs using both a computer-based platform (interactive videodisc) and a television-based platform (Compact Disc-Interactive or CD-I). Members of the Group demonstrate the steps required to produce these programs, including production and collection of video and audio material, instructional design, animation, scripting and programming. Group members also demonstrate finished programs and aiscuss ttle strengths and weaknesses of each delivery platform.
Scientific Exhibit 2
Grids for Scoring Functional Perimetry
Ben Esterman, MD, FACS, Lawrence, NY This exhibit inaugurates the Academy's acquisition of the right to distribute the Esterman Grids which measure peripheral acuity much as the Snellen Chart measures central acuity. Like the Snellen Scale, readings are in percent of normal. Sample field charts, imprinted with Grids, are available. They fit most perimeters including Goldmann type and tangent screens. An automated perimeter, programmed with Esterman Scale, is also exhibited; another, similarly programmed, doubles as a time-saving SCREENER for rapid, automated detection of Scotomas and other field defects, preliminary to more meticulous conventional (Goldmann) perimetry.
Scientific Exhibit 3
Ophthalmic Photographers' Society Annual Photographic Exhibit Bruce J Busse, Lafayette, IN; Ditte Hess, CRA, Miami, FL; Alan
Frohlichstein, CRA, Morton Grove, IL; john Fritch, MD, Lafayette, IN; Christi L Elniff, San Francisco, CA; Ray Swords, CRA, Atlanta, GA; Brian J Busse, CRA, Lafayette, IN; Kenneth julian, CRA, FOPS, Indianapolis, IN; Pat Slopsema, Lafayette, IN The Society presents a large group of photographs, selected by a panel of photographers and ophthalmologists, that represent the finest work submitted by its members. The exhibit features a print and a stereo slide division, each of which contains many categories and encompasses the wide range of diagnostic and documentary photographic applications in ophthalmology.
Scientific Exhibit 4
Five-Year Progress Report from the Collaborative Ocular Melanoma Study
Collaborative Ocular Melanoma Study (COMS) The COMS has recruited patients since 1986 for clinical trials to evaluate enucleation and radiotherapy as treatment for melanoma. As of 3/31/92, 3552 patients have been evaluated, 603 are enrolled (59% of those eligible) in the medium and 662 (82% of eligible) in the large tumor trial. We summarize five years of data, including misdiagnoses and diagnostic accuracy (99.5%), complications of enucleation (3%), presence of pre-existing nonocular cancer (9%), protocol compliance rates (87% for medium, 99% for large) and correlation of clinical, echographic and pathologic size parameters (extremely high).
Scientific Exhibit 5
The Optic Neuritis Treatment Trial (ONTT): A Randomized Study of Corticosteroid Treatment of Acute Optic Neuritis
Roy W Beck, MD, MPH; Optic Neuritis Study, Tampa, FL The ONTI evaluated the efficacy of corticosteroid treatment in 457 patients with acute optic neuritis. Over a six-month follow-up period, patients treated with oral prednisone (1 mglk!Vd X 14d) not only had no better visual outcome, but also had a higher rate of new attacks of optic neuritis (p=0.02) than patients treated with oral placebo. Compared to the placebo group, patients treated with intravenous methylprednisolone (250mg q 6 hrs X 3d) followed by a course of oral prednisone recovered vision faster (p=0.0001) and after six months had slightly better contrast sensitivity (p=O.OS), visual field (p=O.OJ), and color vision (p=O.OJ), but not visual acuity (p=0.66). One-year follow-up data will be available. Treatment guidelines will be given.
Scientific Exhibit 6
Cosmetic Blepharoplasty
Norman Shorr, MD, Beverly Hills, CA; Henry Baylis, MD, Los Angeles, CA; Robert A Goldberg, MD, Los Angeles, CA; Yoash R Enzer, MD, Beverly Hills, CA; Laurie McCall, MD, Los Angeles, CA; Cynthia Boxrud, MD, Beverly Hills, CA; Mark V Garbutt, MD, Los Angeles, CA Cosmetic blepharoplasty differs from functional blepharoplasty both in the approach to the patient and the surgical technique. Ophthalmologists, who have generally concentrated on functional _blepharoplasty, frequently avoid cosmetic surgery because of inexperience. They may be unprepared to deal with the patient's expectations and goals. The exhibit will illustrate with videotapes the surgical technique of cosmetic blepharoplasty and cosmetic eyebrow elevation. The preparation as well as the preoperative and the postoperative management of the cosmetic patient will be stressed.
Scientific Exhibit 7
Ask the Experts
Edwin C Augustat, MD, Fort Worth, TX; Russell W Neuhaus, MD, Austin, TX; Paul T Gavaris, MD, Washington, DC; john B Holds, MD, St. Louis, MO; Myron Tanenbaum, MD, South Miami, FL; john A Burns, MD, Columbus, OH Come by this exhibit for "sidewalk" consultations on your difficult oculoplastic patients, or just to inquire about an interesting case. Two members of the ASOPRS will staff this exhibit on a full:..time basis. Surgery videos will be shown of current surgical techniques of most common oculoplastic disorders, on a request basis.
Scientific Exhibit 8
The Diabetic Retinopathy Education Study: Improving Detection and Referral of Retinopathy by Primary Care Physicians
Howard P Cupples, MD, Washington, DC; Jonathan C Javitt, MD, MPH, Washington, DC; Carl C Awh, MD, Durham, NC; Larry P Chong, MD, Los Angeles, CA; Debra A Street, PhD, Washington, DC; Gladys I Guzman, MS, Washington, DC; Ronald E Smith, MD, Los Angeles, CA We are conducting a multicenter prospective trial designed to test the effectiveness of alternative educational approaches in improving the ability of primary care physicians to appropriately detect and refer patients with sight-threatening diabetic retinopathy. We have developed a new moi:lel eye and an illustrated text for use in this and similar programs. In our pre-test we found that a four-hour course of education that included live patient examination resulted in a 75% decrease (60% vs. 15%; p<.001) in the likelihood that physicians would fail to detect or appropriately refer patients with sight-threatening proliferative retinopathy and an 81% decrease (83% vs. 16%; p<.001) in the likelihood of failing to detect or refer clinically significant macular edema.
:1: The presenter(s) have a financial interest in the subject matter of the presentation
158
Academy scientific exhibits will be displayed Sunday through Wednesday, from 8:00 am - 5:00 pm, and Thursday, from 8:00 am - 3:00 pm.
Exhibits will be staffed throughout the meeting.
157
SCIENTIFIC EXHIBITS Scientific Exhibit 1
*
Developing Interactive Multimedia Instruction for Ophthalmology
Robert Folberg, MD; Laura K Dickinson; Laurie A Smith, Iowa City, lA The Educational Resources Group is a division of the Department of Ophthalmology at the University of Iowa. This group has successfully designed and produced interactive multimedia medical programs using both a computer-based platform (interactive videodisc) and a television-based platform (Compact Disc-Interactive or CD-I). Members of the Group demonstrate the steps required to produce these programs, including production and collection of video and audio material, instructional design, animation, scripting and programming. Group members also demonstrate finished programs and aiscuss ttle strengths and weaknesses of each delivery platform.
Scientific Exhibit 2
Grids for Scoring Functional Perimetry
Ben Esterman, MD, FACS, Lawrence, NY This exhibit inaugurates the Academy's acquisition of the right to distribute the Esterman Grids which measure peripheral acuity much as the Snellen Chart measures central acuity. Like the Snellen Scale, readings are in percent of normal. Sample field charts, imprinted with Grids, are available. They fit most perimeters including Goldmann type and tangent screens. An automated perimeter, programmed with Esterman Scale, is also exhibited; another, similarly programmed, doubles as a time-saving SCREENER for rapid, automated detection of Scotomas and other field defects, preliminary to more meticulous conventional (Goldmann) perimetry.
Scientific Exhibit 3
Ophthalmic Photographers' Society Annual Photographic Exhibit Bruce J Busse, Lafayette, IN; Ditte Hess, CRA, Miami, FL; Alan
Frohlichstein, CRA, Morton Grove, IL; john Fritch, MD, Lafayette, IN; Christi L Elniff, San Francisco, CA; Ray Swords, CRA, Atlanta, GA; Brian J Busse, CRA, Lafayette, IN; Kenneth julian, CRA, FOPS, Indianapolis, IN; Pat Slopsema, Lafayette, IN The Society presents a large group of photographs, selected by a panel of photographers and ophthalmologists, that represent the finest work submitted by its members. The exhibit features a print and a stereo slide division, each of which contains many categories and encompasses the wide range of diagnostic and documentary photographic applications in ophthalmology.
Scientific Exhibit 4
Five-Year Progress Report from the Collaborative Ocular Melanoma Study
Collaborative Ocular Melanoma Study (COMS) The COMS has recruited patients since 1986 for clinical trials to evaluate enucleation and radiotherapy as treatment for melanoma. As of 3/31/92, 3552 patients have been evaluated, 603 are enrolled (59% of those eligible) in the medium and 662 (82% of eligible) in the large tumor trial. We summarize five years of data, including misdiagnoses and diagnostic accuracy (99.5%), complications of enucleation (3%), presence of pre-existing nonocular cancer (9%), protocol compliance rates (87% for medium, 99% for large) and correlation of clinical, echographic and pathologic size parameters (extremely high).
Scientific Exhibit 5
The Optic Neuritis Treatment Trial (ONTT): A Randomized Study of Corticosteroid Treatment of Acute Optic Neuritis
Roy W Beck, MD, MPH; Optic Neuritis Study, Tampa, FL The ONTI evaluated the efficacy of corticosteroid treatment in 457 patients with acute optic neuritis. Over a six-month follow-up period, patients treated with oral prednisone (1 mglk!Vd X 14d) not only had no better visual outcome, but also had a higher rate of new attacks of optic neuritis (p=0.02) than patients treated with oral placebo. Compared to the placebo group, patients treated with intravenous methylprednisolone (250mg q 6 hrs X 3d) followed by a course of oral prednisone recovered vision faster (p=0.0001) and after six months had slightly better contrast sensitivity (p=O.OS), visual field (p=O.OJ), and color vision (p=O.OJ), but not visual acuity (p=0.66). One-year follow-up data will be available. Treatment guidelines will be given.
Scientific Exhibit 6
Cosmetic Blepharoplasty
Norman Shorr, MD, Beverly Hills, CA; Henry Baylis, MD, Los Angeles, CA; Robert A Goldberg, MD, Los Angeles, CA; Yoash R Enzer, MD, Beverly Hills, CA; Laurie McCall, MD, Los Angeles, CA; Cynthia Boxrud, MD, Beverly Hills, CA; Mark V Garbutt, MD, Los Angeles, CA Cosmetic blepharoplasty differs from functional blepharoplasty both in the approach to the patient and the surgical technique. Ophthalmologists, who have generally concentrated on functional _blepharoplasty, frequently avoid cosmetic surgery because of inexperience. They may be unprepared to deal with the patient's expectations and goals. The exhibit will illustrate with videotapes the surgical technique of cosmetic blepharoplasty and cosmetic eyebrow elevation. The preparation as well as the preoperative and the postoperative management of the cosmetic patient will be stressed.
Scientific Exhibit 7
Ask the Experts
Edwin C Augustat, MD, Fort Worth, TX; Russell W Neuhaus, MD, Austin, TX; Paul T Gavaris, MD, Washington, DC; john B Holds, MD, St. Louis, MO; Myron Tanenbaum, MD, South Miami, FL; john A Burns, MD, Columbus, OH Come by this exhibit for "sidewalk" consultations on your difficult oculoplastic patients, or just to inquire about an interesting case. Two members of the ASOPRS will staff this exhibit on a full:..time basis. Surgery videos will be shown of current surgical techniques of most common oculoplastic disorders, on a request basis.
Scientific Exhibit 8
The Diabetic Retinopathy Education Study: Improving Detection and Referral of Retinopathy by Primary Care Physicians
Howard P Cupples, MD, Washington, DC; Jonathan C Javitt, MD, MPH, Washington, DC; Carl C Awh, MD, Durham, NC; Larry P Chong, MD, Los Angeles, CA; Debra A Street, PhD, Washington, DC; Gladys I Guzman, MS, Washington, DC; Ronald E Smith, MD, Los Angeles, CA We are conducting a multicenter prospective trial designed to test the effectiveness of alternative educational approaches in improving the ability of primary care physicians to appropriately detect and refer patients with sight-threatening diabetic retinopathy. We have developed a new moi:lel eye and an illustrated text for use in this and similar programs. In our pre-test we found that a four-hour course of education that included live patient examination resulted in a 75% decrease (60% vs. 15%; p<.001) in the likelihood that physicians would fail to detect or appropriately refer patients with sight-threatening proliferative retinopathy and an 81% decrease (83% vs. 16%; p<.001) in the likelihood of failing to detect or refer clinically significant macular edema.
:1: The presenter(s) have a financial interest in the subject matter of the presentation
158